GLP Watchdog

Embody vs Mochi Health

Neither Embody nor Mochi Health has an FDA warning letter on record. No price lines up like for like. They share compounded semaglutide injection, but Mochi Health's $139 comes with plan terms the seller's page leaves unclear.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Embody / Mochi Health

Featured pick (affiliate partner)

Embody logo

Embody

9.3/10

Mochi Health logo

Mochi Health

7.1/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$79/moCompounded semaglutide injection
$110/moFoundayo (orforglipron) pill
States
All 50 states and DC
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Embody
Visit Mochi Health

Embody is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Mochi Health pays us nothing. The scores are computed the same way for both and are shown as computed (Embody 9.3, Mochi Health 7.1). How we are paid

What the record shows

  1. 01

    Neither Embody nor Mochi Health has an FDA warning letter on record.

  2. 02

    Embody names four pharmacies. Mochi Health names no compounding pharmacy in our record.

  3. 03

    No price lines up like for like. They share compounded semaglutide injection, but Mochi Health's $139 comes with plan terms the seller's page leaves unclear.

  4. 04

    Only Embody lists a price for compounded oral tirzepatide. Only Mochi Health lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and compounded oral semaglutide.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Embody

Mochi Health

Compounded semaglutide injection

$79/mo

$948 a year

$139/mo

plan terms unclear; not compared

Compounded tirzepatide injection

$129/mo

$1,548 a year

$169/mo

plan terms unclear; not compared

Brand-name semaglutide pen
Not sold or not priced

$199/mo

medication only, membership extra; not compared

Brand-name tirzepatide pen
Not sold or not priced

$299/mo

medication only, membership extra; not compared

Compounded oral semaglutide
Not sold or not priced

$141/mo

$1,692 a year

Compounded oral tirzepatide

$329/mo

$3,948 a year

Not sold or not priced
Brand-name semaglutide pill
Not sold or not priced

$149/mo

medication only, membership extra; not compared

Foundayo (orforglipron) pill
Not sold or not priced

$110/mo

$1,320 a year

Price includes
Medication, clinician visits, shipping
Clinician visits, coaching
Billed separately
Not stated
Medication
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the one-month plan; 3-, 6- and 12-month plans are prepaid
None on the monthly plan; 3, 6 and 12-month memberships are prepaid
Refunds
No refunds once paid; a partial refund only after a medical disqualification
No refunds for partly used periods; medication is not refundable once sent to the pharmacy
Early-exit fee
None stated
Not stated

Read off each seller’s own pages. Embody: October 30, 2026. Mochi Health: October 31, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Embody

9.3/10
Featured pick (affiliate partner)
  • Sells compounded oral tirzepatide, which Mochi Health does not price
  • Names its compounding pharmacy
Visit Embody

The case for Mochi Health

7.1/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Embody does not price
  • Names no compounding pharmacy
  • Price leaves out medication
Visit Mochi Health

Scores

Embody 9.3 · Mochi Health 7.1 out of 10. Six weighted parts.

Value25%

10.0A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
7.5

Trust & Safety15%

9.0A
vs
B
8.5

Accessibility10%

10.0A
vs
B
10.0

Support10%

7.0A
vs
B
4.0

The score is the same formula for every seller. Payment does not enter it. Method

Embody vs Mochi Health: questions

Neither Embody nor Mochi Health has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Embody names four pharmacies. Mochi Health names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like. They share compounded semaglutide injection, but Mochi Health's $139 comes with plan terms the seller's page leaves unclear. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Embody states you can cancel at any time; refunds: no refunds once paid; a partial refund only after a medical disqualification. Mochi Health states you can cancel at any time; refunds: no refunds for partly used periods; medication is not refundable once sent to the pharmacy.
Embody is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Mochi Health pays us nothing. The scores are computed the same way for both and are shown as computed (Embody 9.3, Mochi Health 7.1).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks